TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
MMED

MiniMed Group, Inc.

Healthcare · Medical Instruments & Supplies

18.00$ +0.6% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns MiniMed Group, Inc. (MMED)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 100.0% of the shares are freely tradable; institutional investors hold 13.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 13.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 90.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 100.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 72.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 281Mio.

Largest Shareholders

Institutions

Institutions MMED
Name Stake (%) Shares Change (%) Date
Massachusetts Financial Services Company 2.96 8,334,738 +21.2 06/30/2026
Millennium Management LLC 1.09 3,060,615 +18.0 06/30/2026
Citadel Advisors Llc 1.02 2,865,703 +0.5 06/30/2026
Longaeva Partners L.P. 1.00 2,812,970 -11.5 06/30/2026
Sessa Capital, L.P 0.71 2,000,000 +0.0 06/30/2026
BlackRock Inc 0.71 1,996,489 +7,527.5 06/30/2026

Funds

Funds MMED
Name Stake (%) Shares Change (%) Date
iShares Russell 2000 ETF 2.60 7,313,647 +0.0 10/30/2026
MFS Mid Cap Value A 1.52 4,280,011 -0.8 09/30/2026
iShares Russell 2000 Value ETF 0.96 2,711,418 +0.0 10/30/2026
Fidelity Select Medical Tech and Devcs 0.90 2,542,441 +37.4 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings MMED
Person Role Shares Value As of Type
Dianaty Ali EVP Ch. Prod. & Tech Officer 325,817 5,864,706 $ Oct 28, 2026 direct
Chandrasena Gillian SVP, Chief HR Officer 174,545 3,141,810 $ Oct 15, 2026 direct
Denton Sheila A. SVP, Gen. Counsel & Corp. Sec. 58,939 1,060,902 $ Oct 1, 2026 direct
Lofton Kevin E Director 40,409 727,362 $ Oct 15, 2026 direct
Wicks Timothy A Director 25,684 462,312 $ Oct 9, 2026 direct
Eisenberg Glenn A Director 25,684 462,312 $ Oct 9, 2026 direct
Grossman D Keith Director 25,684 462,312 $ Oct 9, 2026 direct
Endicott David J. Director 15,169 273,042 $ Oct 15, 2026 direct
Bricker Amy Director 11,877 213,786 $ Oct 15, 2026 direct
Hopkins Robert (Bob) Director 11,877 213,786 $ Oct 15, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Oct 28, 2026 Dianaty Ali EVP Ch. Prod. & Tech Officer Other 449 18.93 8,500
Oct 15, 2026 Dianaty Ali EVP Ch. Prod. & Tech Officer Other 11,108 – –
Oct 15, 2026 Chandrasena Gillian SVP, Chief HR Officer Other 1,800 – –
Oct 15, 2026 Lofton Kevin E Director Other 836 – –
Oct 15, 2026 Bricker Amy Director Other 11,877 0.00 –
Oct 15, 2026 Hopkins Robert (Bob) Director Other 11,877 0.00 –
Oct 15, 2026 Medtronic plc 10% Owner Other 252,813,348 – –
Oct 15, 2026 Endicott David J. Director Other 3,374 0.00 –
Oct 9, 2026 Endicott David J. Director Other 11,795 0.00 –
Oct 9, 2026 Lofton Kevin E Director Other 11,795 0.00 –
Oct 9, 2026 Wicks Timothy A Director Other 11,795 0.00 –
Oct 9, 2026 Eisenberg Glenn A Director Other 11,795 0.00 –
Oct 9, 2026 Grossman D Keith Director Other 11,795 0.00 –
Oct 1, 2026 Denton Sheila A. SVP, Gen. Counsel & Corp. Sec. Other 58,939 0.00 –

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?